Abiopharma

Clinical trial NCT07348809: primary completion date: 2026-01-15 → 2024-11-02.

Clinical trial NCT06804785 updates: 1. status: RECRUITING → WITHDRAWN 2. enrollment: 800 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05957276 updates: 1. completion date: 2026-07-07 → 2026-07-02 2. enrollment: 887 → 886 participants

Clinical trial NCT07164443: primary completion date: 2027-12-29 → 2028-08-18.

Clinical trial NCT06690827 updates: 1. start date: 2024-11-13 → 2024-12-12 2. completion date: 2028-10-30 → 2028-10-31 3. primary completion date: 2027-10-30 → 2027-06-30

Clinical trial NCT07712874: start date: 2026-09-01 → 2026-09-02.

Clinical trial NCT07549490: start date: 2026-09-01 → 2026-09-02.

Clinical trial NCT07768358: start date: 2026-08-24 → 2026-11-06.

Clinical trial NCT07606339 updates: 1. completion date: 2029-06-15 → 2029-06-10 2. primary completion date: 2029-06-15 → 2029-06-10

Clinical trial NCT07784387 updates: 1. start date: 2026-08-31 → 2026-08-25 2. completion date: 2028-02-29 → 2028-02-25

Clinical trial NCT05185180 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-11 → 2023-03-07 3. primary completion date: 2025-06-01 → 2023-03-07 4. enrollment: 50 → 11 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05299125 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-07-31 → 2025-11-21 3. primary completion date: 2026-01-30 → 2024-08-19

Clinical trial NCT07607600 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 100 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06116786 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 126 → 67 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05986864 updates: 1. completion date: 2026-01-30 → 2027-01-30 2. primary completion date: 2026-01-01 → 2027-01-01